Profile
Christopher Baldwin is currently Chief Commercial Officer at BCAL Diagnostics Ltd. Formerly, Dr. Baldwin was Chief Commercial Officer & Deputy CEO at Exopharm Ltd. from 2021 to 2022 and Executive Director at New York Blood Center, Inc. Education includes a doctorate from Trinity College.
Christopher Baldwin active positions
| Companies | Position | Start |
|---|---|---|
| BCAL DIAGNOSTICS LIMITED | Corporate Officer/Principal | - |
Former positions of Christopher Baldwin
| Companies | Position | End |
|---|---|---|
| EXOPHARM | Corporate Officer/Principal | 2022-01-31 |
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Director/Board Member | - |
Training of Christopher Baldwin
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Health Services |
Trinity College
Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BCAL Diagnostics Ltd.
BCAL Diagnostics Ltd. Medical/Nursing ServicesHealth Services Engages in medical research and testing services | Health Services |
Exopharm Ltd.
Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
- Stock Market
- Insiders
- Christopher Baldwin
















